Modularity of the hydrophobic core and evolution of functional diversity in fold A glycosyltransferases.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
08 2022
Historique:
received: 09 02 2022
revised: 23 06 2022
accepted: 25 06 2022
pubmed: 6 7 2022
medline: 9 9 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

Hydrophobic cores are fundamental structural properties of proteins typically associated with protein folding and stability; however, how the hydrophobic core shapes protein evolution and function is poorly understood. Here, we investigated the role of conserved hydrophobic cores in fold-A glycosyltransferases (GT-As), a large superfamily of enzymes that catalyze formation of glycosidic linkages between diverse donor and acceptor substrates through distinct catalytic mechanisms (inverting versus retaining). Using hidden Markov models and protein structural alignments, we identify similarities in the phosphate-binding cassette (PBC) of GT-As and unrelated nucleotide-binding proteins, such as UDP-sugar pyrophosphorylases. We demonstrate that GT-As have diverged from other nucleotide-binding proteins through structural elaboration of the PBC and its unique hydrophobic tethering to the F-helix, which harbors the catalytic base (xED-Asp). While the hydrophobic tethering is conserved across diverse GT-A fold enzymes, some families, such as B3GNT2, display variations in tethering interactions and core packing. We evaluated the structural and functional impact of these core variations through experimental mutational analysis and molecular dynamics simulations and find that some of the core mutations (T336I in B3GNT2) increase catalytic efficiency by modulating the conformational occupancy of the catalytic base between "D-in" and acceptor-accessible "D-out" conformation. Taken together, our studies support a model of evolution in which the GT-A core evolved progressively through elaboration upon an ancient PBC found in diverse nucleotide-binding proteins, and malleability of this core provided the structural framework for evolving new catalytic and substrate-binding functions in extant GT-A fold enzymes.

Identifiants

pubmed: 35780833
pii: S0021-9258(22)00654-8
doi: 10.1016/j.jbc.2022.102212
pmc: PMC9364030
pii:
doi:

Substances chimiques

Nucleotides 0
Glycosyltransferases EC 2.4.-

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

102212

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM130915
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM139656
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Aarya Venkat (A)

Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA.

Daniel Tehrani (D)

Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA; Complex Carbohydrate Research Center (CCRC), University of Georgia, Athens, Georgia, USA.

Rahil Taujale (R)

Institute of Bioinformatics, University of Georgia, Athens, Georgia, USA.

Wayland Yeung (W)

Institute of Bioinformatics, University of Georgia, Athens, Georgia, USA.

Nathan Gravel (N)

Institute of Bioinformatics, University of Georgia, Athens, Georgia, USA.

Kelley W Moremen (KW)

Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA; Complex Carbohydrate Research Center (CCRC), University of Georgia, Athens, Georgia, USA.

Natarajan Kannan (N)

Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA; Institute of Bioinformatics, University of Georgia, Athens, Georgia, USA. Electronic address: nkannan@uga.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH